Quantitative ultrasound radiomics analysis to evaluate lymph nodes in patients with cancer: a systematic review.
Antonio GuerrisiLudovica MiseoItalia FalconeClaudia MessinaSara UnganiaFulvia EliaFlora DesiderioFabio ValentiVito CantisaniAntonella SorianiMauro CaterinoPublished in: Ultraschall in der Medizin (Stuttgart, Germany : 1980) (2024)
This systematic review aims to evaluate the role of ultrasound (US) radiomics in assessing lymphadenopathy in patients with cancer and the ability of radiomics to predict metastatic lymph node involvement. A systematic literature search was performed in the PubMed (MEDLINE), Cochrane Central Register of Controlled Trials (CENTRAL), and EMBASE (Ovid) databases up to June 13, 2023. 42 articles were included in which the lymph node mass was assessed with a US exam, and the analysis was performed using radiomics methods. From the survey of the selected articles, experimental evidence suggests that radiomics features extracted from US images can be a useful tool for predicting and characterizing lymphadenopathy in patients with breast, head and neck, and cervical cancer. This noninvasive and effective method allows the extraction of important information beyond mere morphological characteristics, extracting features that may be related to lymph node involvement. Future studies are needed to investigate the role of US-radiomics in other types of cancers, such as melanoma.
Keyphrases
- lymph node
- lymph node metastasis
- systematic review
- contrast enhanced
- neoadjuvant chemotherapy
- sentinel lymph node
- magnetic resonance imaging
- squamous cell carcinoma
- small cell lung cancer
- randomized controlled trial
- early stage
- ultrasound guided
- young adults
- convolutional neural network
- contrast enhanced ultrasound
- rectal cancer